Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02119936 · ClinicalTrials.gov registry record · NA
Feasibility of Heart Rate Variability Biofeedback With In-patient Pregnant Women
A NA study, sponsored by University of North Carolina, Chapel Hill.
- Terminated
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT02119936 is a NA study that was terminated before completion, run by University of North Carolina, Chapel Hill. The registered enrollment target is 10 participants.
The verdict
NCT02119936, a NA study, was terminated before completion, sponsored by University of North Carolina, Chapel Hill.
- TERMINATED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Purpose: The investigators plan a feasibility study on an easily disseminated biofeedback tool to reduce stress among hospitalized and expecting mothers. Converging evident suggests that Heart Rate Variability Biofeedback (HRVB) can improve the threshold of stress management and improve executive functioning. Additionally HRVB has been shown to significantly reduce anxiety features in women suffering from perinatal depression. The investigators hypothesize that HRVB will reduce stress levels among expecting mothers hospitalized for pregnancy complications, who are at high risk for depression and anxiety. Participants: Expecting mothers hospitalized for pregnancy complication, who are at high risk for depression and anxiety. Procedures: The investigators plain to use a heart rate variability biofeedback tool to measure stress reduction in hospitalized expectant mothers. This tool will be coupled with validated surveys and scales, high frequency heart rate variability, saliva samples, and qualitative interviews to quantify the reduction in stress from the HRVB tool.
Interventions
- BEHAVIORAL Heart Rate Variability Biofeedback Tool
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02119936
The ClinicalTrials.gov registry entry for NCT02119936 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Heart Rate Variability Biofeedback Tool is the first listed.
NCT02119936 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02119936 about?
NCT02119936 is a clinical study titled "Feasibility of Heart Rate Variability Biofeedback With In-patient Pregnant Women". Purpose: The investigators plan a feasibility study on an easily disseminated biofeedback tool to reduce stress among hospitalized and expecting mothers. Converging evident suggests that Heart Rate Variability Biofeedback (HRVB) can improve the threshold of stress management and improve executive fu...
What is the current status of trial NCT02119936?
This trial is currently terminated. It is a NA study. The enrollment target is 10 participants. The study started on 2014-05. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02119936?
The interventions under investigation include: Heart Rate Variability Biofeedback Tool (BEHAVIORAL).
Who is sponsoring clinical trial NCT02119936?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.